de la Lastra, José M. Pérez
Wardell, Samuel J. T.
Pal, Tarun
de la Fuente-Nunez, Cesar
Pletzer, Daniel
Funding for this research was provided by:
University of Otago
Article History
Received: 10 May 2024
Accepted: 12 July 2024
First Online: 1 August 2024
Declarations
:
: Not applicable.
: Cesar de la Fuente-Nunez provides consulting services to Invaio Sciences and is a member of the Scientific Advisory Boards of Nowture S.L., Peptidus, and Phare Bio. De la Fuente is also on the Advisory Board of the Peptide Drug Hunting Consortium (PDHC). Other authors declare no competing interests.